牙周病市场－全球产业规模、份额、趋势、机会、预测：按治疗方法、最终用户、地区和竞争对手划分，2021-2031年

全球牙周病治疗市场预计将从 2025 年的 21.2 亿美元成长到 2031 年的 31.9 亿美元，复合年增长率为 7.05%。

该行业细分领域涵盖用于预防、诊断和治疗牙周疾病（如牙龈炎和牙周炎）的专业牙科治疗产品和医疗设备，包括局部和全身抗菌剂、手术器械和骨移植材料。市场成长的主要驱动因素是全球人口老化，老年人更容易出现牙周组织退化，以及临床上对口腔健康与糖尿病等全身性疾病之间双向连结的认识不断提高。这些因素正在催生对超越纯粹美学牙科趋势的有效医疗保健管理解决方案的持续需求。

同时，由于报销政策普遍存在缺陷，市场面临许多障碍。这导致许多地区的患者自付费用高昂，治疗顺从性下降。这种经济障碍限制了患者获得先进治疗方法和必要的长期维护通讯协定。根据世界牙科联盟（FDI）2025年的数据，预计全球将有超过10亿人患有严重的牙周疾病，凸显了这种疾病负担与必要治疗的经济可及性之间存在的巨大差距。

市场驱动因素

全球牙周疾病盛行率的不断上升是推动市场扩张的主要动力，持续的治疗性介入已成为基本要求。随着牙龈炎发展为重度牙周炎，工作量也随之增加，需要更多的诊断筛检、洁治和药物治疗。这种基于数量的需求在口腔卫生教育有限的开发中国家尤其突出，但在人口老化的已开发国家，这仍然是一个持续存在的挑战。美国国立卫生研究院 (NIH) 在 2025 年 7 月的一项研究估计，每年新增病例约为 8,960 万例，凸显了需要治疗的新患者数量持续增长。

此外，人们日益认识到口腔健康与慢性疾病之间的系统性联繫，这正在改变治疗通讯协定和患者转诊网络。临床医生正转向整体模式，将牙周管理纳入糖尿病和心血管疾病等全身性疾病的治疗计划中，从而提升牙周管理的地位，使其从选择性的口腔卫生管理提升为必要的医疗保健管理。 2024年11月，欧洲牙周病学会报告称，一项研究发现，糖尿病患者患重度牙周病的可能性是非糖尿病患者的三倍。这项转变也得到了经济趋势的支持，美国牙医协会预测，2025年消费者牙科支出将成长3%，这显示人们对口腔保健的持续投入。

市场挑战

全球牙周病市场面临的一大障碍是普遍缺乏完善的报销政策，这对患者和牙科服务提供者都造成了巨大的经济负担。牙周病治疗的保险覆盖范围有限，迫使患者承担高昂的自付费用，常常导致必要的治疗被延误或拒绝。这种经济限制直接抑制了对先进牙科治疗方法、手术器械和昂贵再生材料的需求，因为患者倾向于选择价格较低或创伤较小的替代方案。

此外，当报销率不足以覆盖营运成本时，牙科诊所往往会避免投资高品质的牙周治疗技术，导致市场停滞不前，儘管临床需求不断增长。根据美国牙科协会 (ADA) 预测，到 2025 年，约 58% 的牙科专业人士会将低报销率和理赔被拒绝视为其诊所永续性和提供最佳护理的主要障碍。这种经济差距有效地抑制了牙周相关产品的商业性化应用，并限制了整个产业的扩张。

市场趋势

将人工智慧 (AI) 应用于预测性诊断，从根本上重塑了牙周病治疗的基础，将临床工作流程从主观评估转变为客观、数据驱动的疾病管理。如今，AI 演算法能够自动量化骨骼水平测量值，并以比传统人工方法更高的精度识别早期放射学骨吸收，从而提高诊断准确性和患者信心。这项技术进步直接促进了收入成长，并透过清晰地向无症状牙周病患者展示治疗必要性，有效弥合了沟通鸿沟。根据 2025 年 7 月《富比士》杂誌的一篇报导（引用 Overjet 的一项调查），72% 的患者表示，如果向他们展示 AI 生成的观察，他们会更容易接受牙医的诊断和治疗方案，这凸显了该技术在提案治疗方法转化为实际治疗方面发挥的关键作用。

同时，再生组织工程和生物製药的进步正在重新定义治疗的可能性，使牙周支持组织的修復不再仅限于阻止疾病进展。临床医生越来越多地使用先进的生物材料，例如生长因子增强型骨移植材料和屏障膜，以促进受损牙齿和植入周围牙周组织的真正再生。这种向生物保存的转变支撑着主要产业参与者强劲的商业性表现，并在普遍的经济逆风中推动了对高品质再生医学产品组合的需求。例如，士卓曼集团在2025年2月报告称，其年销售额将达25亿瑞士法郎。这一数字主要得益于该公司高品质植入和生物材料解决方案在全球主要市场的持续应用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球牙周病市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 治疗方法（非手术治疗（局部抗生素、全身性抗生素、雷射治疗）、手术器械（骨植入、骨移植））
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美牙周病市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲牙周病市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区牙周病市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲牙周病市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲牙周病市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球牙周病市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Periodontal Market is projected to expand from a valuation of USD 2.12 Billion in 2025 to USD 3.19 Billion by 2031, reflecting a CAGR of 7.05%. This industry segment encompasses a specialized array of dental therapeutics and devices aimed at preventing, diagnosing, and treating gum diseases such as gingivitis and periodontitis, including local and systemic antimicrobials, surgical instrumentation, and regenerative bone grafts. The market's growth is fundamentally anchored by an aging global population, which is inherently more prone to periodontal degeneration, alongside rising clinical acknowledgment of the bi-directional link between oral health and systemic issues like diabetes. These drivers generate a lasting demand for effective medical management solutions, distinguishing them from purely cosmetic dental trends.

Conversely, the market encounters significant hurdles due to the widespread insufficiency of reimbursement policies, which result in high out-of-pocket expenses and reduce patient adherence in many areas. This financial obstacle restricts access to advanced therapies and necessary long-term maintenance protocols. Data from the FDI World Dental Federation in 2025 estimated that severe periodontal diseases affected over one billion cases globally, highlighting a profound disparity between the substantial disease burden and the economic accessibility of required treatments.

Market Driver

The escalating global prevalence of periodontal diseases serves as the primary engine for market expansion, establishing a fundamental requirement for continuous therapeutic intervention. As gum conditions advance from gingivitis to severe periodontitis, the clinical workload necessitates a higher volume of diagnostic screenings, scaling procedures, and pharmacological treatments. This volume-based demand is particularly intense in developing nations where oral hygiene education is limited, yet it remains a persistent issue in developed countries due to aging demographics. According to a July 2025 study by the National Institutes of Health on the global burden of periodontal diseases, estimates indicated approximately 89.6 million incident cases in a single year, underscoring the constant influx of new patients requiring care.

Additionally, growing awareness regarding the systemic connection between oral health and chronic diseases is transforming treatment protocols and patient referral networks. Clinicians are increasingly moving toward a holistic model where periodontal management is integrated into care plans for systemic conditions such as diabetes mellitus and cardiovascular disease, elevating it from elective hygiene to essential medical management. The European Federation of Periodontology reported in November 2024 that studies show diabetics face a threefold higher risk of severe gum disease compared to non-diabetics. This shift is supported by economic trends; the American Dental Association recorded a 3% increase in consumer dental spending in 2025, signaling a sustained financial commitment to oral healthcare.

Market Challenge

The widespread absence of adequate reimbursement policies acts as a major impediment to the Global Periodontal Market, creating a significant financial barrier for both patients and dental providers. Limited insurance coverage for periodontal procedures compels patients to shoulder high out-of-pocket costs, often resulting in the delay or refusal of essential treatments. This economic constraint directly dampens the demand for advanced dental therapeutics, surgical instrumentation, and expensive regenerative materials, as patients frequently choose cheaper or less invasive alternatives.

Furthermore, dental practices are discouraged from investing in premium periodontal technologies when compensation rates fail to cover operational costs, leading to market stagnation despite the rising clinical need. According to the American Dental Association, in 2025, approximately 58 percent of dental practitioners identified low insurance reimbursement rates and claim denials as a primary challenge hindering their ability to maintain practice viability and deliver optimal care. This financial disconnect effectively suppresses the commercial adoption of periodontal products and restricts the broader expansion of the sector.

Market Trends

The integration of Artificial Intelligence into predictive diagnostics is fundamentally reshaping the periodontal landscape by shifting clinical workflows from subjective assessment to objective, data-driven disease management. AI algorithms now automatically quantify bone level measurements and identify early-stage radiographic bone loss with a precision that exceeds traditional manual methods, thereby enhancing diagnostic accuracy and patient trust. This technological evolution directly benefits practice revenue cycles by validating treatment necessity to patients who often struggle to visualize asymptomatic gum disease, effectively bridging the communication gap. A July 2025 Forbes article citing an Overjet survey noted that 72% of patients would be more likely to accept a dentist's diagnosis and treatment plan if presented with AI-generated findings, highlighting the technology's critical role in converting proposed therapies into active cases.

Simultaneously, advancements in Regenerative Tissue Engineering and Biologics are redefining therapeutic possibilities by enabling the restoration of lost periodontal support structures rather than merely arresting disease progression. Clinicians are increasingly utilizing advanced biomaterials, such as growth-factor-enhanced bone grafts and barrier membranes, to facilitate true periodontal regeneration around compromised teeth and implants. This shift toward biological preservation is sustaining robust commercial performance for major industry players, driving demand for premium regenerative portfolios despite broader economic headwinds. For instance, the Straumann Group reported in February 2025 that their full-year revenue reached CHF 2.5 billion, a figure significantly bolstered by the continued adoption of their premium implant and biomaterial solutions in key global markets.

Key Market Players

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

Report Scope

In this report, the Global Periodontal Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Periodontal Market, By Therapy

• Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment)
• Surgical Devices (Bone Implants, Bone Grafting)

Periodontal Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Periodontal Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Periodontal Market.

Available Customizations:

Global Periodontal Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Periodontal Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapy (Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment), Surgical Devices (Bone Implants, Bone Grafting))
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Periodontal Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapy
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Periodontal Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapy
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Periodontal Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapy
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Periodontal Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapy
      • 6.3.3.2.2. By End User

7. Europe Periodontal Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapy
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Periodontal Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapy
      • 7.3.1.2.2. By End User
  • 7.3.2. France Periodontal Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapy
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Periodontal Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapy
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Periodontal Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapy
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Periodontal Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapy
      • 7.3.5.2.2. By End User

8. Asia Pacific Periodontal Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapy
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Periodontal Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapy
      • 8.3.1.2.2. By End User
  • 8.3.2. India Periodontal Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapy
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Periodontal Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapy
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Periodontal Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapy
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Periodontal Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapy
      • 8.3.5.2.2. By End User

9. Middle East & Africa Periodontal Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapy
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Periodontal Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapy
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Periodontal Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapy
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Periodontal Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapy
      • 9.3.3.2.2. By End User

10. South America Periodontal Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapy
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Periodontal Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapy
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Periodontal Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapy
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Periodontal Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapy
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Periodontal Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Straumann AG
• 15.3. The 3M Company
• 15.4. Bausch Health Companies Inc.
• 15.5. Dentsply Sirona Group
• 15.6. Pfizer Inc.
• 15.7. Novartis AG
• 15.8. Dentsply Sirona Inc.
• 15.9. Danaher Corporation
• 15.10. GC Corporation

16. Strategic Recommendations

17. About Us & Disclaimer